Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Study of Delayed-Release, Extended-Release Methylphenidate (Jornay PM) in Adolescents and Young Adults With Attention-Deficit/Hyperactivity Disorder and Co-Occurring Cannabis Use Disorder

NCT07838311 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT07838311
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07838311 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Study of Delayed-Release, Extended-Release Methylphenidate (Jornay PM) in Adolescents and Young Adults With Attention-Deficit/Hyperactivity Disorder and Co-Occurring Cannabis Use Disorder
Lead sponsor
Massachusetts General Hospital
Phase
Phase 4
Overall status
Not yet recruiting
Start date
November 30, 2026
Completion date
November 30, 2029
Enrollment
66 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adhd, cannabis use disorder